Financial Snapshot

This section of the Fusion Pharmaceuticals InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Fusion Pharmaceuticals assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQFUSN
Beta(0.04)
Shares Outstanding43.4M
Average Volume (10 days)106.9K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($1.75)
Sales (TTM)$0.05
Book Value (MRQ)$4.58
Cash Flow (TTM)($1.62)
Cash (MRQ)$4.58

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy5
 
Buy1
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Steven Gannon
Director
44,400
Buy
Aug 11, 2022
John Valliant
Director, Chief Executive Officer
(4,511)
Sell
Apr 27, 2022
John Valliant
Director, Chief Executive Officer
(2,147)
Sell
Apr 26, 2022
John Valliant
Director, Chief Executive Officer
(2,036)
Sell
Apr 25, 2022
John Valliant
Director, Chief Executive Officer
(11,994)
Sell
Apr 13, 2022

Recent SEC Filings

Insider Buy/Sell
Aug 11, 2022
Quarterly Financials
Aug 9, 2022
Company Events
Aug 9, 2022
Insider Buy/Sell
Jun 22, 2022
Insider Buy/Sell
Jun 22, 2022
NEVER MISS AN UPDATE